SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,539,910,719 |
| Positions | 5 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| GENERATE BIOMEDICINES INC | GENB | COM SHS | $1,057,295,483 | 62,673,117 |
| MODERNA INC | MRNA | COM | $324,389,395 | 4,632,149 |
| SANA BIOTECHNOLOGY INC | SANA | COM | $87,256,477 | 25,001,856 |
| FOGHORN THERAPEUTICS INC | FHTX | COM | $61,849,706 | 12,674,120 |
| SERES THERAPEUTICS INC | MCRB | COM NEW | $9,119,658 | 1,155,850 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.